These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 20238114)

  • 1. Alpha-type 1-polarized dendritic cells loaded with apoptotic allogeneic myeloma cell line induce strong CTL responses against autologous myeloma cells.
    Yang DH; Kim MH; Hong CY; Lee YK; Jin CJ; Pham TN; Ahn JS; Bae WK; Kim YK; Chung IJ; Kim HJ; Kalinski P; Lee JJ
    Ann Hematol; 2010 Aug; 89(8):795-801. PubMed ID: 20238114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful cross-presentation of allogeneic myeloma cells by autologous alpha-type 1-polarized dendritic cells as an effective tumor antigen in myeloma patients with matched monoclonal immunoglobulins.
    Yang DH; Kim MH; Lee YK; Hong CY; Lee HJ; Nguyen-Pham TN; Bae SY; Ahn JS; Kim YK; Chung IJ; Kim HJ; Kalinski P; Lee JJ
    Ann Hematol; 2011 Dec; 90(12):1419-26. PubMed ID: 21465188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of potent cytotoxic T lymphocytes against castration-resistant prostate cancer cells by dendritic cells loaded with dying allogeneic prostate cancer cells.
    Hwang EC; Lim MS; Im CM; Kwon DD; Lee HJ; Nguyen-Pham TN; Lee YK; Lee JJ
    Scand J Immunol; 2013 Feb; 77(2):117-24. PubMed ID: 23126536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dendritic cells containing apoptotic melanoma cells prime human CD8+ T cells for efficient tumor cell lysis.
    Jenne L; Arrighi JF; Jonuleit H; Saurat JH; Hauser C
    Cancer Res; 2000 Aug; 60(16):4446-52. PubMed ID: 10969791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dendritic cells fused with allogeneic breast cancer cell line induce tumor antigen-specific CTL responses against autologous breast cancer cells.
    Zhang Y; Ma B; Zhou Y; Zhang M; Qiu X; Sui Y; Zhang X; Ma B; Fan Q
    Breast Cancer Res Treat; 2007 Nov; 105(3):277-86. PubMed ID: 17187233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dendritic cells fused with allogeneic colorectal cancer cell line present multiple colorectal cancer-specific antigens and induce antitumor immunity against autologous tumor cells.
    Koido S; Hara E; Homma S; Torii A; Toyama Y; Kawahara H; Watanabe M; Yanaga K; Fujise K; Tajiri H; Gong J; Toda G
    Clin Cancer Res; 2005 Nov; 11(21):7891-900. PubMed ID: 16278414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting heat shock proteins for immunotherapy in multiple myeloma: generation of myeloma-specific CTLs using dendritic cells pulsed with tumor-derived gp96.
    Qian J; Wang S; Yang J; Xie J; Lin P; Freeman ME; Yi Q
    Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8808-15. PubMed ID: 16361569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of myeloma-specific cytotoxic T lymphocytes ex vivo by CD40-activated B cells loaded with myeloma tumor antigens.
    Kim SK; Nguyen Pham TN; Nguyen Hoang TM; Kang HK; Jin CJ; Nam JH; Chung SY; Choi SJ; Yang DH; Kim YK; Chung IJ; Kim HJ; Lee JJ
    Ann Hematol; 2009 Nov; 88(11):1113-23. PubMed ID: 19277657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of potent cytotoxic T lymphocytes against in male patients with non-muscle invasive bladder cancer by dendritic cells loaded with dying T24 bladder cancer cells.
    Hwang EC; Jung SI; Lee HJ; Lee JJ; Kwon DD
    Int Braz J Urol; 2017; 43(4):615-627. PubMed ID: 28266813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autologous dendritic cells loaded with apoptotic tumor cells induce T cell-mediated immune responses against breast cancer in vitro.
    Delirezh N; Moazzeni SM; Shokri F; Shokrgozar MA; Atri M; Kokhaei P
    Cell Immunol; 2009; 257(1-2):23-31. PubMed ID: 19306994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allogeneic GM-CSF-secreting tumor cell immunotherapies generate potent anti-tumor responses comparable to autologous tumor cell immunotherapies.
    Li B; Simmons A; Du T; Lin C; Moskalenko M; Gonzalez-Edick M; VanRoey M; Jooss K
    Clin Immunol; 2009 Nov; 133(2):184-97. PubMed ID: 19664962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of potent antitumor CTL from patients with multiple myeloma directed against HM1.24.
    Rew SB; Peggs K; Sanjuan I; Pizzey AR; Koishihara Y; Kawai S; Kosaka M; Ozaki S; Chain B; Yong KL
    Clin Cancer Res; 2005 May; 11(9):3377-84. PubMed ID: 15867238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha-Type 1 Polarized Dendritic Cells Loaded with Apoptotic Allogeneic Breast Cancer Cells Can Induce Potent Cytotoxic T Lymphocytes against Breast Cancer.
    Park MH; Yang DH; Kim MH; Jang JH; Jang YY; Lee YK; Jin CJ; Pham TN; Thi TA; Lim MS; Lee HJ; Hong CY; Yoon JH; Lee JJ
    Cancer Res Treat; 2011 Mar; 43(1):56-66. PubMed ID: 21509164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of leukemia-specific cytotoxic response by cross-presentation of late-apoptotic leukemic blasts by autologous dendritic cells of nonleukemic origin.
    Spisek R; Chevallier P; Morineau N; Milpied N; Avet-Loiseau H; Harousseau JL; Meflah K; Gregoire M
    Cancer Res; 2002 May; 62(10):2861-8. PubMed ID: 12019165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activation of cytotoxic T-lymphocytes by hTERT-pulsed dendritic cells.
    Kryukov F; Ocadlíková D; Kovárová L; Buresová I; Hájek R; Michálek J
    J Immunotoxicol; 2009 Dec; 6(4):243-8. PubMed ID: 19908943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro induction of tumor-specific human lymphocyte antigen class I-restricted CD8 cytotoxic T lymphocytes by ovarian tumor antigen-pulsed autologous dendritic cells from patients with advanced ovarian cancer.
    Santin AD; Hermonat PL; Ravaggi A; Bellone S; Pecorelli S; Cannon MJ; Parham GP
    Am J Obstet Gynecol; 2000 Sep; 183(3):601-9. PubMed ID: 10992180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of myeloma-specific cytotoxic T lymphocytes responses by natural killer cells stimulated-dendritic cells in patients with multiple myeloma.
    Nguyen-Pham TN; Im CM; Nguyen TA; Lim MS; Hong CY; Kim MH; Lee HJ; Lee YK; Cho D; Ahn JS; Yang DH; Kim YK; Chung IJ; Kim HJ; Lee JJ
    Leuk Res; 2011 Sep; 35(9):1241-7. PubMed ID: 21612823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dendritic cell-tumor cell hybrids enhance the induction of cytotoxic T lymphocytes against murine colon cancer: a comparative analysis of antigen loading methods for the vaccination of immunotherapeutic dendritic cells.
    Yasuda T; Kamigaki T; Nakamura T; Imanishi T; Hayashi S; Kawasaki K; Takase S; Ajiki T; Kuroda Y
    Oncol Rep; 2006 Dec; 16(6):1317-24. PubMed ID: 17089056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Specific cell immune response mediated by dendritic cells in multiple myeloma patients in vitro].
    Qi H; Shen JK; Xiao L; Zhang GS
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Apr; 31(2):222-7. PubMed ID: 16706120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RNA loading of leukemic antigens into cord blood-derived dendritic cells for immunotherapy.
    Hsu AK; Kerr BM; Jones KL; Lock RB; Hart DN; Rice AM
    Biol Blood Marrow Transplant; 2006 Aug; 12(8):855-67. PubMed ID: 16864056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.